New blood test registry aims to improve neuroendocrine tumor care
Knowledge-focused
ENROLLING_BY_INVITATION
This registry is collecting blood samples and health data from 400 people with neuroendocrine tumors. The goal is to see if a new blood test called NETest can help detect tumor activity and predict disease progression. Participants include patients before and after surgery, those…
Sponsor: Wren Laboratories LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC